Avera Health Releases Clinical Validation of PGx Panel for Depression Treatment Optimization
NEW YORK — A pharmacogenomic panel developed at Avera Health has shown overall clinical benefit when used within the healthcare system to guide treatment for patients with depression, according to a study published last month. Patients who received pharmacogenetic results and related pharmacist recommendations experienced improvements in mental quality of life, depression severity and clinical …
